Eterna Therapeutics terminates San Diego office lease; consolidates R&D to Cambridge, MA

Ernexa Therapeutics Inc.

Entered lease termination agreement for 5,193 sq ft office at 10355 Science Center Drive, San Diego.
Lease will terminate if Landlord re-lets premises by Jan 15, 2023; effective Feb 28, 2023.
Termination fee of $100,000 payable in two installments; otherwise lease expires June 2027.
Termination aligns with previously announced decision in Q2 2022 to consolidate R&D in Cambridge, MA.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Ernexa Therapeutics Inc. terminated Termination Agreement with Torrey Pines Science Center Limited Partnership valued at $100,000 (effective 2022-11-30).

Action: termination
Agreement: lease
Counterparty: Torrey Pines Science Center Limited Partnership
Value: $100,000
Effective: 2022-11-30

Exact text from the filing

On November 30, 2022, Eterna Therapeutics Inc., a Delaware corporation (the “ Company ”), entered into a lease termination agreement (the “ Termination Agreement ”) with Torrey Pines Science Center Limited Partnership, a Delaware limited partnership (“ Landlord ”), to terminate that certain lease agreement (the “ Lease ”), dated as of March 31, 2022

View on SEC.gov

Browse all material agreements →

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001140361-22-044598

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.